Michael G. Carter, Director at Oncternal Therapeutics, Inc. (ONCT), bought 142,858 shares at $2.10 ($300K) on 2020-09-01, disclosed to the SEC on 2020-09-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 71,429 | $150K | 50.0% |
| 2 | $2.10 | 71,429 | $150K | 50.0% |
| Total | $2.10 avg | 142,858 | $300K | 100% |